Related Experiment Video
Updated: Sep 18, 2025
Models of Bone Metastasis
Published on: September 4, 2012
Osteosclerotic changes on computed tomography predict disease progression and poor survival in prostate cancer with
Meiting Chen1, Zhenhua Yang2,3, Shuai Yang2
1Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Background:
Radiographic progression-free survival (rPFS) in prostate cancer (PC) may not always accurately reflect tumor progression. However, the prognostic significance of osteosclerotic changes (OCs) in PC remains unclear.
Methods:
A training cohort of 152 PC patients with osteoblastic metastases was recruited from the Sun Yat-sen University Cancer Center, while a validation cohort of 41 patients was obtained from two additional hospitals. Patients were stratified into two groups based on computed tomography findings: those with OCs and those without OCs (no osteosclerotic change [NOC]). Clinical outcomes were subsequently analyzed.
Results:
In the training cohort, 103 and 49 patients were classified into the OC and NOC groups, respectively. A significantly higher proportion of radiographic progression was observed in the OC group than in the NOC group (72.8% vs. 51.0%, P = 0.0105). The OC group demonstrated significantly worse rPFS and overall survival (OS) than the NOC group (median rPFS: 11.6 months vs. 52.9 months, P < 0.0001, median OS: 30.7 months vs. 67.1 months, P < 0.0001). Multivariate analysis identified OC as an independent prognostic factor for poor rPFS and OS. The results were validated in an external cohort.
Conclusion:
OCs are associated with adverse survival outcomes and may serve as potential biomarkers for disease progression and reduced survival in PC patients with osteoblastic metastases.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT